申请人:Abbott Laboratories
公开号:US06242494B1
公开(公告)日:2001-06-05
A class of substituted b-amino acids are potent inhibitor of methionine aminopeptidase type 2 (MetAP2) and are thus useful in inhibiting angiogenesis and disease conditions which depend upon angiogenesis for their development such as diabetic retinopathy, tumor growth, and conditions of inflammation. Pharmaceutical compounds containing the compounds and methods of inhibiting methionine aminopeptidase-2, and angiogenesis are also disclosed.
一类取代的β-氨基酸是对蛋氨酸氨基肽酶2(MetAP2)的强效抑制剂,因此在抑制依赖血管生成发展的疾病状况(如糖尿病视网膜病变、肿瘤生长和炎症状况)方面非常有用。还披露了包含这些化合物的药物化合物以及抑制蛋氨酸氨基肽酶-2和血管生成的方法。